Sign In
Buy IHE
$101.62
-0.84 (-0.82%)
At Close: Jul 31, 2026
IHE: Healthcare Dashboard For June
01:24pm, Wednesday, 18'th Jun 2025
The healthcare providers industry is undervalued by about 22% versus 11-year averages, while pharma/biotech and life science tools trade near historical baseline in valuation. IHE ETF offers exposure
ETFs on the Move Post U.S.-China Trade Deal
01:55pm, Monday, 12'th May 2025
Let's delve into the ETF world following the 90-day U.S.-China trade deal.
Pharma ETFs in Focus on Trump's Drug Price Overhaul
11:31am, Monday, 12'th May 2025
Trump's plan to slash the price of prescription drugs by 30% put pharma ETFs in focus.
A Look at Pharma ETFs After Strong Q1 Earnings
12:50pm, Thursday, 08'th May 2025
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:20am, Monday, 28'th Apr 2025
Launched on 05/01/2006, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity mar
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:20am, Monday, 24'th Feb 2025
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on
ETFs Poised to Win or Lose Under Trump's New Policies
11:11am, Tuesday, 21'st Jan 2025
Donald Trump commences his second term by enacting a series of executive orders. The actions are poised to create winners and losers across different industries.
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs
07:05am, Friday, 17'th Jan 2025
For many of us, a new year often means a new chance to start fresh in our battle with weight. Thanks to interesting ETF product development, especially in the past year, it could also mean a chance to
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:21am, Monday, 23'rd Dec 2024
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on
IHE Contraction Is Not Justified By Fundamental Data
09:30pm, Thursday, 21'st Nov 2024
iShares U.S. Pharmaceuticals ETF is a pharmaceutical ETF offered by iShares, featuring an expense ratio of 0.39% and over $500 million in assets under management. In Q3, the healthcare sector reported
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:20am, Monday, 21'st Oct 2024
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fun
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:21am, Tuesday, 20'th Aug 2024
Launched on 05/01/2006, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity mar
Pharma ETFs in Focus Post Solid Q2 Earnings
12:51pm, Wednesday, 14'th Aug 2024
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Disruptive Theme of the Week: Playing Defense
08:39am, Wednesday, 14'th Aug 2024
When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.
IHE: Significant Growth Ahead, But Valuation Not Cheap (Rating Downgrade)
11:07pm, Wednesday, 24'th Jul 2024
IHE invests in large-cap U.S. pharmaceutical stocks with solid long-term growth outlook but high concentration risk. IHE's fund price has been steady with a positive trend in 2024, but its elevated va
